Clinical Manufacture

Commercial Manufacture

Drug Product Fill & Finish




Antibody Drug Conjugates

Technologies & Platforms
Chinese Premier Li Keqiang Visits WuXi PharmaTech’s Headquarters in Shanghai
Apr 01, 2013

SHANGHAI, April 1, 2013 — Chinese Premier Li Keqiang visited WuXi PharmaTech’s headquarters in Shanghai on March 28, 2013. The visit was part of the first research tour by the newly elected Chinese Premier since assuming office in March 2013.

Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, accompanied Premier Li on the tour of research laboratories. “We are very excited to host Premier Li at WuXi,” said Dr. Ge Li. “He always pays close attention to the healthcare industry and the well-being of Chinese people. WuXi will continue to strengthen our platform to enable more companies, organizations and entrepreneurs to discover and develop better therapeutic products for patients.”

Premier Li’s visit highlights WuXi’s leadership in China’s life science industries. It also highlights the role of innovation in fostering the country’s growth and improving quality of life for Chinese patients. China’s strategic investment in healthcare aims to make available more effective and affordable treatments for diseases prevalent in the Chinese population, and WuXi strives to become the partner-of-choice for its global collaborators to bring more innovative products to the fastest growing China healthcare market.